Portfolio company
Vibe Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence software for biopharmaceutical firms to evaluate drug assets and also invests in therapeutics for rare diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pharos IBT
This company develops artificial intelligence platforms for discovering and developing treatments for rare and refractory diseases for the pharmaceutical and biotechnology industries.
Serna Bio
This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.
Valohealth
This company develops an artificial intelligence platform for drug discovery and development to assist pharmaceutical partners in creating new medical treatments.
Formation Bio
This company develops in-licensed clinical-stage drug candidates for pharmaceutical and biotechnology partners using a proprietary artificial intelligence platform to accelerate trials.
Diffuse Bio
This company develops generative artificial intelligence software and experimental screening platforms for protein design and validation for pharmaceutical and biotechnology researchers.
Xaira
The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.
Creyon Bio
This company develops AI-designed oligonucleotide-based medicines and RNA-targeted therapies for pharmaceutical partners and patients with neuromuscular and immunological diseases.
Healx
Healx develops an AI-driven drug discovery platform to identify treatments for rare diseases for pharmaceutical partners and patient advocacy groups.
